• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺癌的体液标志物。

Humoral markers for thyroid carcinoma.

作者信息

Pacini F, Martino E, Bambini G, Aghini-Lombardi F, Taddei D, Lari R, Pinchera A, Baschieri L

出版信息

Cancer Detect Prev. 1985;8(1-2):17-22.

PMID:4064037
Abstract

We investigated the usefulness and limits of serum thyroglobulin, serum calcitonin, and serum tissue polypeptide antigen as humoral markers for thyroid carcinoma in 364 patients with papillary, follicular, medullary, and undifferentiated types of thyroid cancer. In agreement with other studies we found that serum thyroglobulin was a specific and sensitive marker for well-differentiated thyroid cancer after total thyroidectomy. Lymph node, lung, and bone metastases were associated with high serum thyroglobulin concentrations, both during and after thyroid-suppressive therapy with L-thyroxine. Serum thyroglobulin determination was superior to whole body scanning in predicting the presence of differentiated metastases, because patients with nonfunctioning metastases and negative whole body scan also had high levels of serum thyroglobulin. Serum calcitonin levels were increased in all patients with active medullary thyroid cancer, confirming the specificity of this marker in detecting tumors arising from parafollicular C-cells. Furthermore, in medullary thyroid cancer serum tissue polypeptide antigen levels were also increased in most patients. This last substance was found to be increased also in undifferentiated thyroid cancer. Of particular interest was the finding of increased serum tissue polypeptide antigen levels in 15 cases of differentiated thyroid cancer, whose metastases underwent a progressive process of "dedifferentiation."

摘要

我们研究了血清甲状腺球蛋白、血清降钙素和血清组织多肽抗原作为甲状腺癌体液标志物在364例乳头状、滤泡状、髓样和未分化型甲状腺癌患者中的有用性和局限性。与其他研究一致,我们发现血清甲状腺球蛋白是全甲状腺切除术后分化型甲状腺癌的特异性和敏感标志物。在使用左旋甲状腺素进行甲状腺抑制治疗期间和之后,淋巴结、肺和骨转移均与血清甲状腺球蛋白浓度升高有关。血清甲状腺球蛋白测定在预测分化型转移灶的存在方面优于全身扫描,因为无功能转移灶且全身扫描阴性的患者血清甲状腺球蛋白水平也很高。所有活动性髓样甲状腺癌患者的血清降钙素水平均升高,证实了该标志物在检测滤泡旁C细胞来源肿瘤方面的特异性。此外,在髓样甲状腺癌中,大多数患者的血清组织多肽抗原水平也升高。发现这种最后一种物质在未分化甲状腺癌中也升高。特别有趣的是,在15例分化型甲状腺癌中发现血清组织多肽抗原水平升高,这些病例的转移灶经历了一个逐渐“去分化”的过程。

相似文献

1
Humoral markers for thyroid carcinoma.甲状腺癌的体液标志物。
Cancer Detect Prev. 1985;8(1-2):17-22.
2
[Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].[甲状腺切除术后分化型甲状腺癌患者血清甲状腺球蛋白及抗甲状腺球蛋白抗体的临床意义]
Magy Onkol. 2004;48(1):27-34. Epub 2004 Apr 23.
3
Follow-up of differentiated thyroid carcinoma.分化型甲状腺癌的随访
Minerva Endocrinol. 2004 Dec;29(4):161-74.
4
[Useful and limits of the biochemical markers for the diagnosis of thyroid carcinoma].[用于甲状腺癌诊断的生化标志物的作用与局限性]
Ann Ital Chir. 2006 May-Jun;77(3):209-14.
5
[Thyroid carcinoma].[甲状腺癌]
Gan To Kagaku Ryoho. 2005 Apr;32(4):561-5.
6
[Standards, options and recommendations for blood tumor markers in thyroid cancers].[甲状腺癌血液肿瘤标志物的标准、选择及建议]
Bull Cancer. 2001 Aug;88(8):775-92.
7
Serum thyroglobulin measurements in differentiated thyroid cancer.分化型甲状腺癌的血清甲状腺球蛋白检测
Biomed Pharmacother. 2000 Jul;54(6):330-3. doi: 10.1016/S0753-3322(00)80058-X.
8
[Immunohistochemical and serological demonstration of thyreoglobulin tissue polypeptide antigen, carcinoembryonic antigen and calcitonin in diversely differentiated thyroid gland carcinomas and thyroid gland adenomas].
Pathologe. 1985 May;6(3):133-40.
9
Surgery of thyroid cancer: twelve years' personal experience.甲状腺癌手术:十二年个人经验
Acta Otorhinolaryngol Ital. 2004 Dec;24(6):348-53.
10
Serum thyroglobulin determinations in patients with differentiated thyroid carcinoma.分化型甲状腺癌患者的血清甲状腺球蛋白测定
Nuklearmedizin. 1983 Aug;22(4):204-11.